[
  {
    "ts": null,
    "headline": "Merck expects cancer therapy Keytruda to be part of government price setting in 2026",
    "summary": "Drugmaker Merck said onTuesday it expects its top selling cancer therapy Keytruda to beselected in 2026 for government price setting, which wouldbecome effective on January 1, 2028. ...",
    "url": "https://finnhub.io/api/news?id=ca01ed1f9e95dc26a962ee21a680677c2ecc6739e790680d73938efd3f996d89",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740502284,
      "headline": "Merck expects cancer therapy Keytruda to be part of government price setting in 2026",
      "id": 132873339,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Drugmaker Merck said onTuesday it expects its top selling cancer therapy Keytruda to beselected in 2026 for government price setting, which wouldbecome effective on January 1, 2028. ...",
      "url": "https://finnhub.io/api/news?id=ca01ed1f9e95dc26a962ee21a680677c2ecc6739e790680d73938efd3f996d89"
    }
  },
  {
    "ts": null,
    "headline": "MRK Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
    "summary": "Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. and certain of its...",
    "url": "https://finnhub.io/api/news?id=885fc6a841cdfd9ec3ca1c1f1c1dd4eb154ee811c68e838055aa68741b9bd5bd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740499323,
      "headline": "MRK Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
      "id": 132872878,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. and certain of its...",
      "url": "https://finnhub.io/api/news?id=885fc6a841cdfd9ec3ca1c1f1c1dd4eb154ee811c68e838055aa68741b9bd5bd"
    }
  },
  {
    "ts": null,
    "headline": "Law Offices of Frank R. Cruz Encourages Merck & Co (MRK) Investors to Inquire About Securities Fraud Class Action",
    "summary": "The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Merck & Co securities between February 3, 2022, to February 3, 2025,...",
    "url": "https://finnhub.io/api/news?id=c58c75a82dcbf92fc07347281e62be6f8bbb70f8310ed16b2820c949c08fe105",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740485284,
      "headline": "Law Offices of Frank R. Cruz Encourages Merck & Co (MRK) Investors to Inquire About Securities Fraud Class Action",
      "id": 132871746,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Merck & Co securities between February 3, 2022, to February 3, 2025,...",
      "url": "https://finnhub.io/api/news?id=c58c75a82dcbf92fc07347281e62be6f8bbb70f8310ed16b2820c949c08fe105"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Select Large Cap Equity Fund Q4 2024 Commentary",
    "summary": "Columbia Select Large Cap Equity Fund Institutional Class shares returned 3.31% for\nthe three months ending 12/31/2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=369b0d4f7df570e328865349cf6db51f8334ceaaecb1211fafe021f4b172669c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740478800,
      "headline": "Columbia Select Large Cap Equity Fund Q4 2024 Commentary",
      "id": 132871223,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1707046352/image_1707046352.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Columbia Select Large Cap Equity Fund Institutional Class shares returned 3.31% for\nthe three months ending 12/31/2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=369b0d4f7df570e328865349cf6db51f8334ceaaecb1211fafe021f4b172669c"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.",
    "summary": "Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.",
    "url": "https://finnhub.io/api/news?id=8d842d83f6441922524668fd84310b88e154005d92e6ffaab42931a7a420916f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740477240,
      "headline": "Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.",
      "id": 132881609,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.",
      "url": "https://finnhub.io/api/news?id=8d842d83f6441922524668fd84310b88e154005d92e6ffaab42931a7a420916f"
    }
  },
  {
    "ts": null,
    "headline": "10 Undervalued Dividend Growth Stocks: February 2025",
    "summary": "10 Undervalued Dividend Growth Stocks: February 2025",
    "url": "https://finnhub.io/api/news?id=712bdbf6ff26876ba20b43ef010c2f165ae8a0261b7c844089b2f5a9c9a4686a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740474000,
      "headline": "10 Undervalued Dividend Growth Stocks: February 2025",
      "id": 132870866,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=712bdbf6ff26876ba20b43ef010c2f165ae8a0261b7c844089b2f5a9c9a4686a"
    }
  },
  {
    "ts": null,
    "headline": "Merck Gets Speedy FDA Review of Keytruda in Certain Head, Neck Cancers",
    "summary": "By Colin Kellaher Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with...",
    "url": "https://finnhub.io/api/news?id=5b62b158e17bb748a702dd955af48a950064407d9b3bc76730a8a9ebbd0c327b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740469087,
      "headline": "Merck Gets Speedy FDA Review of Keytruda in Certain Head, Neck Cancers",
      "id": 132870120,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with...",
      "url": "https://finnhub.io/api/news?id=5b62b158e17bb748a702dd955af48a950064407d9b3bc76730a8a9ebbd0c327b"
    }
  },
  {
    "ts": null,
    "headline": "MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, Feb. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc.  for violations...",
    "url": "https://finnhub.io/api/news?id=813b468bdfa314b8cccfb3a454752851dfce5afe16b5eb554842b7d0badaa4fa",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740467224,
      "headline": "MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 132869862,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Feb. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc.  for violations...",
      "url": "https://finnhub.io/api/news?id=813b468bdfa314b8cccfb3a454752851dfce5afe16b5eb554842b7d0badaa4fa"
    }
  },
  {
    "ts": null,
    "headline": "FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma",
    "summary": "Acceptance based on results from the KEYNOTE-689 trial: the first Phase 3 trial to demonstrate significant improvement in event-free survival in the neoadjuvant and adjuvant setting for an anti-PD-1...",
    "url": "https://finnhub.io/api/news?id=410c653113978f71b69aa2f8de1abe872f61b1bc83bd95b1a07e8f1b44d2f37a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740465964,
      "headline": "FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma",
      "id": 132869656,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Acceptance based on results from the KEYNOTE-689 trial: the first Phase 3 trial to demonstrate significant improvement in event-free survival in the neoadjuvant and adjuvant setting for an anti-PD-1...",
      "url": "https://finnhub.io/api/news?id=410c653113978f71b69aa2f8de1abe872f61b1bc83bd95b1a07e8f1b44d2f37a"
    }
  },
  {
    "ts": null,
    "headline": "Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky",
    "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=b48ba71cac078a380da8ec223e9ea7610ee9a001157c3e14ed067e1fcd320058",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740462384,
      "headline": "Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky",
      "id": 132869337,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=b48ba71cac078a380da8ec223e9ea7610ee9a001157c3e14ed067e1fcd320058"
    }
  }
]